Advances in Therapy, 0741-238X


More filtering options
  1. 2019
  2. Maximum Tolerated Dose and Pharmacokinetics of Paclitaxel Micellar in Patients with Recurrent Malignant Solid Tumours: A Dose-Escalation Study

    Borgå, O., Henriksson, R., Bjermo, H., Lilienberg, E., Heldring, N. & Niklas Loman, 2019, In : Advances in Therapy. 36, 5, p. 1150-1163

    Research output: Contribution to journalArticle

  3. 2017
  4. 2015
  5. Randomized, Double-Blind, Dose-Finding Study for Tiotropium when Added to Olodaterol, Administered via the Respimat(®) Inhaler in Patients with Chronic Obstructive Pulmonary Disease.

    Aalbers, R., Maleki-Yazdi, M. R., Hamilton, A., Waitere-Wijker, S., Zhao, Y., Amatto, V. C., Schmidt, O. & Leif Bjermer, 2015, In : Advances in Therapy. 32, 9, p. 809-822

    Research output: Contribution to journalArticle

  6. 2013
  7. A Novel Formulation of Mometasone Furoate in Psoriasis Patients: A Multicenter, Randomized, Double-Blind Clinical Study

    Berg, M., Åke Svensson & Faergemann, J., 2013, In : Advances in Therapy. 30, 5, p. 503-516

    Research output: Contribution to journalArticle

  8. 2005
  9. Epoetin alfa and darbepoetin alfa for the treatment of chemotherapy-related anemia in cancer patients in sweden: comparative analysis of drug utilization, costs, and hematologic response.

    Persson, U., Borg, S., Jansson, S., Ekman, T., Franksson, L., Friesland, S. & Larsson, A-M., 2005, In : Advances in Therapy. 22, 3, p. 208-24

    Research output: Contribution to journalArticle